The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores
Liver-based measures of systemic inflammation (CAR and mGPS) appear more reliable for the quantification of the magnitude of SIR and have prognostic value in patients with advanced NSCLC.
Authors
- Sarah Will
- Barry J. A. Laird (ORCID: https://orcid.org/0000-0002-2807-6192)
- Ross D. Dolan (ORCID: https://orcid.org/0000-0002-5272-5906)
- C Maseland
- John D. Maclay (ORCID: https://orcid.org/0000-0002-2531-7712)
- Josh McGovern (ORCID: https://orcid.org/0000-0002-6889-6240)
- Nicholas MacLeod
- Donald C. McMillan (ORCID: https://orcid.org/0000-0003-4260-5334)
- Elise Cranfield
- Fraser O'Rourke
- Hanh Thi Ngoc Nguyen
Institutions
- Beatson West of Scotland Cancer Centre (GB)
- Glasgow Royal Infirmary (GB)
- Institute of Genetics and Cancer (GB)
- University of Glasgow (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/cam4.70139
- Citations
- 5
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.41